Fabio M. Iwamoto, MD

Peter C. Pan, MD is a board-certified assistant professor of neurology in the Division of Neuro-Oncology. He specializes in the treatment of brain tumors. He studied molecular biology and neurobiology at the University of California Berkeley, medicine at the State University of New York Downstate, and clinical neurology residency at the University of California Davis. He completed subspecialty training in Neuro-Oncology at NewYork-Presbyterian / Columbia University Irving Medical Center and NewYork-Presbyterian Weill Cornell Medical Center.

Dr. Winawer's clinical and research interests are in the genetics of epilepsy and Long COVID. Her research focuses on identifying genetic contributions to human health and disease with a focus on epilepsy, incorporating expertise in genetic epidemiology, human translational neuroscience, animal models, and imaging. Her recent work has led to the identification of the emerging role of somatic brain localized mutations in individuals with intractable focal epilepsy. Clinically, since the beginning of the COVID-19 pandemic, Dr. Winawer has become CUIMC’s expert in the neurological care of individuals with lasting sequelae of COVID-19, and in collaboration with the department of Infectious Disease, she has helped to form a multidisciplinary foundation-funded center for care and research of infection associated chronic conditions (IACCS) including Long COVID.

Dr. Kuo is a Movement Disorders specialist caring for patients with cerebellar ataxia, including spinocerebellar ataxia and multiple system atrophy, and a variety of other movement disorders, such as essential tremor and Parkinson’s disease. As a physician-scientist, his research is funded by National Institutes of Health to study the role of the cerebellum in movement disorders, implicating in ataxia and tremor. He leads a multi-disciplinary research team to study the disease mechanism and to develop therapies for movement disorders via translational research and clinical trials. Dr. Kuo is the Director for the Initiative for Columbia Ataxia and Tremor (ICAT), an interdisciplinary research group to study how the cerebellum plays a role in neurological and neurodegenerative disorders. He also serves as one of the tri-leaders for the Clinical Research Consortium for Spinocerebellar Ataxias, constituting 15 medical centers in the U.S. to study patients living with spinocerebellar ataxias. Aiming to promote research collaboration, Dr. Kuo organizes International Tremor Congress every other year, bringing researchers together to advance therapies for tremor. He was elected in 2020 as the Vice Chair for the Movement Disorders Section at American Academy of Neurology. Dr. Kuo has received multiple scientific awards as the recognition of his contributions to neurology, including 2016 Louis V. Gerstner Jr. Scholar Merit Award, 2019 American Academy of Neurology Jon Stolk Award for Movement Disorders, and 2020 American Neurological Association Derek Denny-Brown Award.